Govt orders safety review of popular weight-loss drugs amid rising demand

›
Indian authorities are increasing vigilance on popular weight loss drugs. The Indian Pharmacopoeia Commission will now compile reports on ad...

Why healthcare access still depends on affordability in India, and how universal insurance may change that

›
India's healthcare system faces affordability challenges despite infrastructure advancements, with out-of-pocket spending causing financ...

India's 'Mounjaro brides': Weight-loss injections become part of pre-wedding preparation

›
With wedding season in full swing, Indian health clinics are rolling out specialized weight-loss packages that include popular drugs such as...

Indian pharma sector faces supply risk amid West Asia conflict despite duty waiver

›
India's pharmaceutical industry faces ongoing concerns about securing essential petrochemical supplies due to the West Asia conflict. Wh...

Emcure cuts semaglutide injection price by average 47%

›
The starting dose price is cut by 55% to Rs 3,999 per month (four weekly doses). The innovator semaglutide is available in a once-weekly pen...

Emcure slashes prices of weight management drug Poviztra by up to 55%

›
Emcure Pharmaceuticals is making its weight management drug Poviztra more accessible. The price of the semaglutide injection will be cut by ...

Lilly's weight-loss pill wins US approval, sets up next battle with rival Novo Nordisk

›
The US FDA has approved Eli Lilly's new weight-loss pill, Foundayo. This marks a significant step in the ongoing competition with rival ...